Moderna reaches vaccine settlement, GitLab's guidance disappoints

Market Intelligence Analysis

AI-Powered
Why This Matters

Moderna's shares surged after reaching a settlement over its COVID vaccine patent, while GitLab's sales slowed due to disappointing 2027 earnings guidance. The NASDAQ climbed following jobs data and potential Iran-US negotiations. The market is experiencing mixed sentiment.

Market Impact

Market impact analysis based on bullish sentiment with 70% confidence.

Sentiment
Bullish
AI Confidence
70%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Yahoo Finance anchor Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute. US stock exchanges, in particular the NASDAQ (^IXIC, ^GSPC, ^DJI), climb following jobs data and news of potential Iran-US negotiations. Moderna (MRNA) shares jump after reaching a settlement concerning its COVID vaccine patent. And GitLab (GTLB) sales slow with the announcement of lackluster 2027 earnings guidance. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Continue Reading
Full article on Yahoo Finance
Read Full Article
Original article published by Yahoo Finance on March 4, 2026.
Analysis and insights provided by AnalystMarkets AI.